文献速递产科麻醉区域麻醉与超声

中国女性预防性宫颈环扎术罗哌卡因中位有效剂量研究

Median effective dose of ropivacaine for prophylactic cervical cerclage in Chinese women: a dose-finding study.
PubMed 文献 · Reg Anesth Pain Med · 2022-12-30

本研究纳入40例在腰硬联合麻醉下接受预防性宫颈环扎术的中国女性,采用序贯法确定鞘内等比重罗哌卡因的ED50和ED95。结果显示ED50为6.9 mg(95%CI,6.68至7.12 mg),计算ED95为7.8 mg(95%CI,7.69至10.05 mg)。

要点

  • 鞘内罗哌卡因用于宫颈环扎术的ED50为6.9 mg(95%CI,6.68至7.12 mg)。
  • 计算ED95为7.8 mg(95%CI,7.69至10.05 mg)。
  • 23例(57.5%)仅用鞘内罗哌卡因即获有效阻滞,17例(42.5%)需追加硬膜外利多卡因。

核心结论

  • 预防性宫颈环扎术鞘内罗哌卡因的ED50为6.9 mg(95%CI,6.68至7.12 mg)。
  • 7.8 mg鞘内罗哌卡因可能使95%的患者获得成功麻醉(计算ED95,95%CI,7.69至10.05 mg)。

研究设计与样本

  • 前瞻性剂量探索研究,纳入40例在腰硬联合麻醉下接受预防性宫颈环扎术的中国女性(妊娠早期或中期)。
  • 采用序贯法,初始剂量后根据阻滞是否达T12水平调整剂量,每次增减0.5 mg。
  • 主要结局为鞘内罗哌卡因的ED50,次要结局包括计算ED95、从腰硬联合麻醉到手术开始时间等。

主要发现

  • 40例中23例(57.5%)仅用鞘内罗哌卡因即获有效阻滞,17例(42.5%)需追加硬膜外利多卡因。
  • 等渗回归法确认的ED50为6.9 mg(95%CI,6.68至7.12 mg)。
  • 计算ED95为7.8 mg(95%CI,7.69至10.05 mg)。
  • 仅用鞘内罗哌卡因获有效阻滞时,感觉和运动阻滞消退时间分别为90(75-100)min和90(60-100)min。

关键数值与推荐

  • 有效阻滞定义为阻滞平面不低于T12。
  • 序贯法剂量调整幅度为0.5 mg。

临床怎么用

  • 预防性宫颈环扎术可考虑鞘内罗哌卡因7.8 mg以使95%患者获得成功麻醉。
  • 部分患者(本研究为42.5%)可能需要追加硬膜外利多卡因以达到有效阻滞。
  • 仅用鞘内罗哌卡因时感觉和运动阻滞消退时间分别约为90 min和90 min,需据此规划术后监测。

局限性

  • 研究仅纳入中国女性,结果外推至其他人群需谨慎。
  • 样本量40例,ED95为计算值,需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although intrathecal ropivacaine has been widely used for caesarean delivery, there are limited data for the use of ropivacaine for prophylactic cervical cerclage. We sought to determine the median effective dose of intrathecal ropivacaine for prophylactic cervical cerclage in 50% of patients (ED50) and the calculated dose required for successful block in 95% of patients (ED95). METHODS: We included Chinese women scheduled for prophylactic cervical cerclage under combined spinal-epidural (CSE) anaesthesia in the first or second trimester. A predetermined dose of intrathecal isobaric ropivacaine was administered. If this determined dose achieved an effective block at a level not lower than T12, the next dose was decreased by 0.5 mg. Otherwise, the next dose was increased by 0.5 mg. The primary outcome was the ED50 of intrathecal ropivacaine. Secondary outcomes included the calculated ED95, time from CSE to the start of surgery and so on. RESULTS: Forty patients were included in the study, 23 (57.5%) of 40 received an effective block only with intrathecal ropivacaine, while 17 (42.5%) patients needed extra epidural lidocaine to achieve a successful block. The ED50 of intrathecal ropivacaine confirmed by isotonic regression was 6.9 mg (95% CI, 6.68 to 7.12 mg), and the calculated ED95 was 7.8 mg (95% CI, 7.69 to 10.05 mg). When an effective block was achieved with intrathecal ropivacaine alone, the time to resolution of the sensory and motor blocks was 90 (75-100) min and 90 (60-100) min, respectively. CONCLUSIONS: The ED50 of intrathecal ropivacaine for prophylactic cervical cerclage was 6.9 mg. Intrathecal ropivacaine (7.8 mg) is likely to produce successful anaesthesia in 95% of patients undergoing prophylactic cervical cerclage. TRIAL REGISTRATION NUMBER: ChiCTR2100051418.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Liu K, Zhao P, Ding M, et al. Median effective dose of ropivacaine for prophylactic cervical cerclage in Chinese women: a dose-finding study. Reg Anesth Pain Med. 2022. PMID: 36585039. doi:10.1136/rapm-2022-104242

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。